Skip to search formSkip to main contentSkip to account menu

Disorat

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Metipranolol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
[Pharmacokinetics of the beta-receptor blocker metipranolol in patients with liver cirrhosis (author's transl)].
The pharmacokinetics after oral administration of the beta-blocker metipranolol (Disorat) were investigated in 20 patients with… 
2004
2004
Metipranolol and propranolol: No CNS effects of a single oral dose
Effects of single oral doses of the β-blocking drugs propranolol (40 mg) and metipranolol (Disorat, Boehringer, Mannheim, FRG, 5… 
1979
1979
[Metabolic effects of a fixed combination (betablocker plus saluretic) in long-term treatment of arterial hypertension (author's transl)].
UNLABELLED In 23 patients with essential hypertension of stage I and II according to the WHO, the effects of a fixed combination… 
1979
1979
Pharmakokinetik von Metipranolol (Disorat) bei normaler und eingeschränkter Nierenfunktion
Metipranolol1 ist ein Beta-Rezeptoren-Blocker ohne Membraneigenwirkung und ohne „intrinsic activity”. Informationen uber… 
1977
1977
Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
The new beta-blockers 4-(2-hydroxy-3-isopropyl-amino-propoxy)-carbazole (carazolol) and 1-(4-acetoxy-2,3,5-trimethylphenyloxy)-3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)